Marketplace interviewed Partner Greg Husisian about the Foreign Investment Risk Review Modernization Act for the story “Congress Weighs Changes to Foreign Investment Oversight.” The legislation is intended to give the Committee on Foreign Investment in the United States new powers and more funding as the United States government grapples with how to best limit Chinese investment in critical technologies such as semiconductors and mobile broadband. The legislation would build on existing export controls and cover other types of deals such as joint ventures.
“That’s the part I find most fascinating. They’re looking at other situations,” Husisian said. “By requiring a kind of licensing scheme, they can potentially slow down or block the transfer of very important economic and national security type of information.”
“That’s the part I find most fascinating. They’re looking at other situations,” Husisian said. “By requiring a kind of licensing scheme, they can potentially slow down or block the transfer of very important economic and national security type of information.”
People
Related News
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."
July 18, 2025
In the News
Aaron Maguregui Highlights Potential Compliance Concerns in Pre-Tax Wellness Claims
Foley & Lardner LLP partner Aaron Maguregui commented in The New York Times article, "Hot Dogs for Insomnia? A Kennedy Aide's Start-Up Can Get You a Tax Break," sharing insight on the growing use of medical necessity letters to support tax-advantaged purchases of wellness products.